Author: Colin Pettis

Colin Pettis covers the senior semiconductor sector and is a managing director at Tech Insider, joining in 2012. Colin has 20 years of experience in equity research including 15 years in semiconductor components. Colin is currently responsible for the coverage of 18 large-cap and small-cap semiconductor companies.
Finance

Biotech Volatile Stocks: Lexicon Pharmaceuticals (NASDAQ:LXRX), Corcept Therapeutics Incorporated (NASDAQ:CORT), Insys Therapeutics (NASDAQ:INSY), ANI Pharmaceuticals (NASDAQ:ANIP)

Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX), just announced a positive, top-line result in a Phase 2 clinical trial of their experimental therapy LX4211 in type 1 diabetes. LX4211, an oral, first-in-class, dual inhibitor of sodium glucose transporters 1 and 2, was designed to lower blood glucose levels through two insulin-independent mechanisms of action. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) stock performance was 5.16% in last session and finished the … Continue reading Biotech Volatile Stocks: Lexicon Pharmaceuticals (NASDAQ:LXRX), Corcept Therapeutics Incorporated (NASDAQ:CORT), Insys Therapeutics (NASDAQ:INSY), ANI Pharmaceuticals (NASDAQ:ANIP)

Colin Pettis
Finance

Biotech New Lows: ArQule (NASDAQ:ARQL), OvaScience Inc (NASDAQ:OVAS), Uniqure (NASDAQ:QURE), Egalet Corp (NASDAQ:EGLT)

ArQule Inc. (NASDAQ:ARQL) announced that the Company will present at the Needham 13th Annual Healthcare Conference. The presentation will be web cast and may be accessed through the investor relations section of the Company’s website http://www.arqule.com. ArQule, Inc. (NASDAQ:ARQL) stock performance was -2.92% in last session and finished the day at $1.66. Traded volume was 530,559.00million shares in the last session and the average volume … Continue reading Biotech New Lows: ArQule (NASDAQ:ARQL), OvaScience Inc (NASDAQ:OVAS), Uniqure (NASDAQ:QURE), Egalet Corp (NASDAQ:EGLT)

Colin Pettis
Finance

Hot Movers: Sony Corp (ADR) (NYSE:SNE), Advanced Micro Devices (NYSE:AMD), NVIDIA Corporation (NASDAQ:NVDA), QUALCOMM (NASDAQ:QCOM)

Yesterday, Sony Corporation (ADR) (NYSE:SNE) announced that they are selling SCE’s 9,520,000 shares in Square Enix to one of the biggest Japanese brokerage firms, SMBC Nikko Securities. The analyst predicted that the deal will net Sony Corporation (ADR) (NYSE:SNE) 4.8 billion YEN which is “47 million dollars”. Sony Corp (ADR) (NYSE:SNE) stock performance was 1.24% in last session and finished the day at $18.78. Traded … Continue reading Hot Movers: Sony Corp (ADR) (NYSE:SNE), Advanced Micro Devices (NYSE:AMD), NVIDIA Corporation (NASDAQ:NVDA), QUALCOMM (NASDAQ:QCOM)

Colin Pettis
Finance

Active Movers at NYSE: Facebook Inc (NASDAQ:FB), Yahoo! Inc. (NASDAQ:YHOO), Intel Corporation (NASDAQ:INTC), Sirius XM Holdings Inc. (NASDAQ:SIRI)

The world’s largest search engine, along with Facebook Inc (NASDAQ:FB) and Twitter, which are due to report financial results in coming weeks, are revamping their products and advertising business to account for smartphones. Facebook Inc (NASDAQ:FB) stock performance was 1.07% in last session and finished the day at $59.72. Traded volume was 78.77million shares in the last session and the average volume of the stock … Continue reading Active Movers at NYSE: Facebook Inc (NASDAQ:FB), Yahoo! Inc. (NASDAQ:YHOO), Intel Corporation (NASDAQ:INTC), Sirius XM Holdings Inc. (NASDAQ:SIRI)

Colin Pettis
Finance

Biotech Unusual Volume: Zalicus Inc (NASDAQ:ZLCS), ImmunoGen (NASDAQ:IMGN), Transition Therapeutics (NASDAQ:TTHI), Lpath (NASDAQ:LPTN)

Zalicus Inc (NASDAQ:ZLCS) will merge with Epirus Biopharmaceuticals in an all-stock transaction. Zalicus will be known as Epirus and will operate under the latter company’s management team led by Amit Munshi as president and CEO. Current Zalicus Inc (NASDAQ:ZLCS) stockholders will own approximately 19% of the company. The merger will create a publicly-traded company listed on the NASDAQ. Zalicus Inc (NASDAQ:ZLCS) stock performance was 31.07% … Continue reading Biotech Unusual Volume: Zalicus Inc (NASDAQ:ZLCS), ImmunoGen (NASDAQ:IMGN), Transition Therapeutics (NASDAQ:TTHI), Lpath (NASDAQ:LPTN)

Colin Pettis
Finance

Small Cap New Highs: Key Energy Services (NYSE:KEG), Comstock Resources (NYSE:CRK), Capstead Mortgage (NYSE:CMO), Knight Transportation (NYSE:KNX)

Deutsche Bank restated their buy rating on shares of Key Energy Services (NYSE:KEG) in a research note issued to investors on Monday, Analyst Ratings Network.com reports. The firm currently has a $12.00 price target on the stock. Key Energy Services (NYSE:KEG) traded up 0.51% on Monday, hitting $9.85. 1,952,295 shares of the company’s stock traded hands. Key Energy Services, Inc. (NYSE:KEG) stock performance was 0.92% … Continue reading Small Cap New Highs: Key Energy Services (NYSE:KEG), Comstock Resources (NYSE:CRK), Capstead Mortgage (NYSE:CMO), Knight Transportation (NYSE:KNX)

Colin Pettis